(Q30011154)

English

Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety Study

scientific article published in April 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Yang XJ

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

Lecksell K

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

Short K

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

Gottesman J

4

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

Peterson L

5

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

Bannow J

6

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

Schellhammer PF

7

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

Fitch WP

8

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

Hodge GB

9

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

Parra R

10

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

Rouse S

11

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

Waldstreicher J

12

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

Epstein JI

13

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

language of work or name

0 references

publication date

1 April 1999

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

696-700

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Benign prostatic hyperplasia. Medical and minimally invasive treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

5 Alpha-reductase inhibitory and anti-androgenic activities of some 4-azasteroids in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical development of a 5α-reductase inhibitor, finasteride

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Qualitative and quantitative evaluation of prostatic histomorphology in rats following chronic treatment with finasteride, a 5-alpha reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostatic effects induced in dogs by chronic or acute oral administration of 5 alpha-reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Finasteride dose-dependently reduces the proliferation rate of the LnCap human prostatic cancer cell line in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of castration, DES, flutamide, and the 5α-reductase inhibitor, MK-906, on the growth of the dunning rat prostatic carcinoma, R-3327

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Transition zone volume and transition zone ratio: predictor of uroflow response to finasteride therapy in benign prostatic hyperplasia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter, randomized, double-blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety Stud

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoprevention of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900579-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(98)00579-2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30011154&oldid=1856206978"